CannabisNewsBreaks

WednesdayJun 14, 2017 9:25 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Targets Canadian Cannabis Market by Incorporating CBD Biotechnology Inc. in British Columbia

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. “I am delighted about the incorporation of CBD Biotechnology Inc.,” Warren Wang, founder and CEO of CIIX, stated in the news release. “The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX's goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health.” Canada promises to play a major role…

Continue Reading

TuesdayJun 13, 2017 9:00 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Teams with Pharmaseed to Advance Development of INM-750

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into an agreement with Pharmaseed Ltd., Israel’s largest GLP-certified pre-clinical contract research organization. Under the terms of this agreement, the Pharmaseed development team will now play a key role in the ongoing development of InMed’s lead compound, INM-750, which is a proprietary, topical cannabinoid product candidate that’s currently being studied as a therapy in epidermolysis bullosa and other potential dermatological and wound-healing applications. “This agreement with Pharmaseed now adds one of Israel's leading formulation development teams to our efforts and represents an important strategic…

Continue Reading

MondayJun 12, 2017 8:55 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Becomes Exclusive Licensee of Cannabis-Based Treatment for Alzheimer’s Disease

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its entry into a definitive license agreement with the University of South Florida that makes the company the exclusive licensee of the U.S. patent filing entitled ‘THC as a Potential Therapeutic Agent for Alzheimer’s Disease’. If the patent filing is granted and proven, IGC anticipates that it could create a “significant therapeutic pathway” in the Alzheimer’s disease market, which is expected to record direct costs in excess of $450 billion annually in the next 12 years. “Securing this…

Continue Reading

WednesdayJun 07, 2017 3:13 pm

CannabisNewsBreaks – Player’s Network (PNTV) Shares Continue Two-Day Streak, Set Second New High this Week

Shares of Player’s Network (OTCQB: PNTV) are up 7% at $0.10 near market close, moving on volume of 5.83 million and setting a new 52-week high for the third time since last Friday. On June 2, PNTV announced (http://nnw.fm/2s34T) that its majority owned Green Leaf Farms subsidiary had completed the first phase of construction for its marijuana cultivation and production facility in North Las Vegas. This achievement was preceded by news earlier in the week that Green Leaf received two Nevada state-issued recreational marijuana licenses, as well as medical marijuana licenses (http://nnw.fm/9XLst). PNTV said the licenses create another revenue stream…

Continue Reading

WednesdayJun 07, 2017 10:15 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Pursues Clinical Trials of Cannabis-Based Combination Therapies with Assistance of New Advisor

India Globalization Capital (NYSE MKT: IGC) recently named Craig Cheifetz, M.D. as an advisor to assist the company with its clinical trials in microbiology, immunology, neuroscience and biotechnology. IGC CEO Ram Mukunda stated in a news release that the company looks forward to Dr. Cheifetz’s contributions as IGC moves forward in the development of unique cannabis combination therapies. “The company anticipates clinical trials in 2017 for several indications, including pain, a huge market. IGC has already filed for six patents in areas such as eating disorders and epilepsy, in addition to pain. It is working on several more filings for…

Continue Reading

TuesdayJun 06, 2017 3:22 pm

CannabisNewsBreaks – Player’s Network, Inc. (PNTV) Rips to New 52-Week High on Quadruple Volume following Series of Corporate Milestones

Shares of Player’s Network (OTCQB: PNTV) are up 25% in today’s late trade, clipping a new 52-week high of $0.093 and moving on volume of 11.91 million – four times the 30-day moving average of 2.78 million. Today’s performance eclipses the 52-week high of $0.075 set at market close on June 2 and continues several days of rallies fueled by a string of corporate achievements. On May 30, PNTV said it received (http://nnw.fm/8AbNW) its medical marijuana licenses, enabling the company to start operations in its 27,000-square-foot facility in North Las Vegas and pushing the stock to the sixth-highest volume on…

Continue Reading

TuesdayJun 06, 2017 9:27 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Teams with First Bitcoin Capital (BITCF) to Develop Bitcoin Payments Solution

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced an initiative to develop a bitcoin payments solution in partnership with First Bitcoin Capital Corp. (OTC: BITCF), an industry-leading bitcoin and blockchain technology provider. Per the news release, the two companies have signed a joint venture agreement to develop and distribute a viable payments solution targeted at “high-risk payment verticals including the cannabis industry” in order to “fill the payments gap that currently exists.” Through this new partnership, SinglePoint and First Bitcoin Capital intend to focus on their respective core strengths in order to build and supply the best bitcoin…

Continue Reading

FridayJun 02, 2017 9:39 am

NetworkNewsBreak – Player’s Network, Inc. (PNTV) Completes First Phase of Construction for Green Leaf Farms Cultivation and Production Facility

Player’s Network, Inc. (OTCQB: PNTV) this morning announced the completion of the the first phase of its 27,000-sq.-ft. facility being built in North Las Vegas for its subsidiary Green Leak Farms Holdings. mCig, Inc. (OTCQB: MCIG), the company contracted to develop and build out the facility, worked with the City of North Las Vegas and the State of Nevada to ensure Green Leaf was 100% compliant. The first phase included two vegetation and flower rooms, an extraction lab and all the needed infrastructure to support the facility. According to the press release, phase 2 and phase 3 are nearing completion…

Continue Reading

ThursdayJun 01, 2017 12:41 pm

NetworkNewsBreak – Player’s Network, Inc.’s (PNTV) Green Leaf Subsidiary Receives Two Nevada Recreational Marijuana Licenses

Player’s Network (OTCQB: PNTV) has received its recreational marijuana licenses, issued by the State of Nevada, which permits the company to supply recreational marijuana products to retail dispensaries based in the state. The company’s achievement comes two days after the company said it received two state-issued medical licenses to operate its 27,000-square-foot facility in North Las Vegas. Green Leaf Farms Holdings, LLC, the company’s subsidiary, has now met all requirements to begin selling to the recreational market and is anticipated to be able to distribute marijuana to Nevada dispensaries with the new licenses as soon as July 1, 2017. "Qualifying…

Continue Reading

WednesdayMay 31, 2017 10:55 am

CannabisNewsBreaks – Cannabis Wheaton (TSXV: CBW) to Invest $30M in ABcann Global Corporation (TSXV: ABCN) for Construction of Additional Cannabis Cultivation Facility

Medical cannabis grower ABcann Global (TSXV: ABCN) is set to receive an investment of $30 million from Cannabis Wheaton Income (TSXV: CBW) for the funding of a 50,000-square-foot cultivation space at ABcann’s proposed facility to be located in Napanee, Ontario. Per a binding interim agreement announced earlier this week, Cannabis Wheaton’s investment will fund the construction of an “expansion production area” that is in addition to ABcann’s 100,000-square foot-facility, which is expected to commence construction “imminently.” Cannabis Wheaton will receive 50% of the proceeds (net of certain costs) of future wholesale or retail sales completed by ABcann with respect to…

Continue Reading